The novel treatment of this peptide represents a exciting development in the management of type 2 diabetes. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide119745.ampedpages.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-69055275